Jonathan Schechter - 20 Nov 2023 Form 4 Insider Report for PharmaCyte Biotech, Inc. (PMCB)

Role
Director
Signature
/s/ Jonathan L. Schechter
Issuer symbol
PMCB
Transactions as of
20 Nov 2023
Net transactions value
$0
Form type
4
Filing time
22 Nov 2023, 17:01:06 UTC
Previous filing
01 Jun 2023
Next filing
10 Apr 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMCB Stock Option (Right to Buy) Award $0 +61,248 $0.000000 61,248 20 Nov 2023 Common Stock 61,248 $2.18 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.